Cancer/ News/ News/ Oncology/ R&D/ Top stories Roche pays $1.7 billion for cancer specialist Ignyta Andrew McConaghie ignyta, NSCLC, Roche 0 Comment Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta. The San Diego based Share X Roche pays $1.7 billion for cancer specialist Ignyta https://pharmaphorum.com/news/roche-pays-1-7-billion-cancer-specialist-ignyta/
Cancer/ News/ News/ Oncology/ R&D/ Top stories/ US After surging on lung cancer data, Ignyta looks to raise $160m Andrew McConaghie cancer, ignyta, lung cancer 0 Comment San Diego based biotech firm Ignyta is capping off a week of success with a public stock offering Share X After surging on lung cancer data, Ignyta looks to raise $160m https://pharmaphorum.com/news/surging-lung-cancer-data-ignyta-looks-raise-160m/
